{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:23:12Z","timestamp":1780539792091,"version":"3.54.1"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/01679"],"award-info":[{"award-number":["PI23\/01679"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01109"],"award-info":[{"award-number":["PI20\/01109"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Regional Government of Andalusia Ministry of Health and Consumer Affairs","doi-asserted-by":"publisher","award":["PECART-0091-2020"],"award-info":[{"award-number":["PECART-0091-2020"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.critrevonc.2025.104622","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T19:49:49Z","timestamp":1737229789000},"page":"104622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Small cell lung cancer unveiled: Exploring the untapped resource of circulating tumor cells-derived organoids"],"prefix":"10.1016","volume":"207","author":[{"given":"Jes\u00fas A.","family":"P\u00e9rez-Cabello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Artero-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-2453","authenticated-orcid":false,"given":"Sonia","family":"Molina-Pinelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104622_bib1","doi-asserted-by":"crossref","unstructured":"A. De Luca, M. Gallo, C. Esposito, A. Morabito, N. Normanno, cancers Promising Role of Circulating Tumor Cells in the Management of SCLC, (2021). https:\/\/doi.org\/10.3390\/cancers.","DOI":"10.3390\/cancers13092029"},{"key":"10.1016\/j.critrevonc.2025.104622_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104622_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.21037\/tlcr-21-819","article-title":"Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer","volume":"11","author":"Acheampong","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabi\u00e8res","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2025.104622_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/PPO.0000000000000148","article-title":"Management of small cell lung cancer: progress and updates","volume":"21","author":"Altan","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.critrevonc.2025.104622_bib6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-44404-y","article-title":"Circulating tumor cell cluster phenotype allows monitoring response to treatment and predicts survival","volume":"9","author":"Balakrishnan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib8","article-title":"Drug susceptibility testing of circulating lung cancer cells for personalized treatment","volume":"40","author":"Balakrishnan","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/carcin\/bgy174","article-title":"Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization","volume":"40","author":"Banerjee","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2025.104622_bib10","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41467-021-22336-4","article-title":"Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes","volume":"12","author":"Bebber","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104622_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2023.01.012","article-title":"Current and emerging treatment options for patients with relapsed small-cell lung carcinoma: a systematic literature review","author":"Bernab\u00e9-Caro","year":"2023","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jtho.2021.02.009","article-title":"Efficacy and safety of rovalpituzumab tesirine compared with topotecan as second-line therapy in DLL3-high SCLC: results from the phase 3 TAHOE study","volume":"16","author":"Blackhall","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123729","article-title":"Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy","volume":"12","author":"Boyero","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-0716-2193-6_18","article-title":"Negative-selection enrichment of circulating tumor cells from peripheral blood using the microfluidic CTC-iChip","volume":"2471","author":"Burr","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10147-017-1105-2","article-title":"Circulating tumor cells: clinical validity and utility","volume":"22","author":"Cabel","year":"2017","journal-title":"Int J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2022.11.014","article-title":"Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification","volume":"175","author":"Caliman","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00728-3","article-title":"Tracking cancer progression: from circulating tumor cells to metastasis","volume":"12","author":"Castro-Giner","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.critrevonc.2025.104622_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","article-title":"Tumor organoid\u2013T-cell coculture systems","volume":"15","author":"Cattaneo","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.critrevonc.2025.104622_bib20","first-page":"105","author":"Chemi","year":"2020","journal-title":"Circ. Tumour Cells Lung Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41591-019-0593-1","article-title":"Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse","volume":"25","author":"Chemi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1084\/jem.20181155","article-title":"Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells","volume":"216","author":"Chen","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122586","article-title":"Liquid biopsy in small cell lung cancer-a route to improved clinical care?","volume":"9","author":"Church","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104622_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032558","article-title":"Enumeration and characterization of circulating tumor cells in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"24","author":"Espejo-Cruz","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104622_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2025.104622_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.104622_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12071930","article-title":"Circulating tumor cell detection technologies and clinical utility: challenges and opportunities","volume":"12","author":"Habli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00408-015-9725-7","article-title":"Circulating tumor cells in small cell lung cancer: ex vivo expansion","volume":"193","author":"Hamilton","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.critrevonc.2025.104622_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/19336918.2016.1155019","article-title":"Small cell lung cancer: circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype","volume":"10","author":"Hamilton","year":"2016","journal-title":"Cell Adh Migr."},{"key":"10.1016\/j.critrevonc.2025.104622_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tlcr-22-712","article-title":"Significance of circulating tumor cells in lung cancer: a narrative review","volume":"12","author":"Hamilton","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib31","first-page":"762","article-title":"Role of circulating tumor cell spheroids in drug resistance","volume":"2","author":"Hamilton","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.critrevonc.2025.104622_bib32","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-05-2821","article-title":"Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival","volume":"12","author":"Hayes","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib33","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000366","article-title":"Controversies in oncology: surgery for small cell lung cancer? It\u2019s time to rethink the case","volume":"3","author":"Hoda","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2025.104622_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"Hodgkinson","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib37","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1002\/cam4.2199","article-title":"Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential","volume":"8","author":"Hu","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00271","article-title":"A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer","volume":"4","author":"Huang","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib39","article-title":"Next-Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC-derived organoids","author":"Huang","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.critrevonc.2025.104622_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10030072","article-title":"Update on immunohistochemistry for the diagnosis of lung cancer","volume":"10","author":"Inamura","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.683318","article-title":"Survival, chemotherapy and chemosensitivity predicted by CTC cultured in vitro of SCLC patients","volume":"11","author":"Ju","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib42","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.21037\/tlcr-20-521","article-title":"Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer","volume":"9","author":"Kapeleris","year":"2020","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104622_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nprot.2017.125","article-title":"Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device","volume":"13","author":"Khoo","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.critrevonc.2025.104622_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05562-z","article-title":"Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance","volume":"7","author":"Klameth","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib45","first-page":"39","article-title":"Small cell lung cancer (SCLC): no treatment advances in recent years","volume":"5","author":"Koinis","year":"2016","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104622_bib46","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2025.104622_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21037\/tlcr.2017.08.01","article-title":"Circulating tumor cells and CDX models as a tool for preclinical drug development","volume":"6","author":"Lallo","year":"2017","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104622_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113394","article-title":"Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/cyto.a.23507","article-title":"ClearCell\u00ae FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells","volume":"93","author":"Lee","year":"2018","journal-title":"Cytom. A"},{"key":"10.1016\/j.critrevonc.2025.104622_bib50","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.21037\/tcr.2020.01.17","article-title":"Strategies for enrichment of circulating tumor cells","volume":"9","author":"Li","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.semcancer.2022.05.010","article-title":"Molecular subtyping of small cell lung cancer","volume":"86","author":"Liang","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13030390","article-title":"Surgery in small-cell lung cancer","volume":"13","author":"Martucci","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semcancer.2022.05.004","article-title":"Small cell lung cancer: novel treatments beyond immunotherapy","volume":"86","author":"Meijer","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1878-0261.12802","article-title":"Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients","volume":"15","author":"Mendelaar","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib55","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s41598-018-20502-1","article-title":"Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent\/refractory small cell lung cancer treated with pazopanib","volume":"8","author":"Messaritakis","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib56","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cyto.a.23571","article-title":"The Parsortix\u2122 cell separation system-a versatile liquid biopsy platform","volume":"93","author":"Miller","year":"2018","journal-title":"Cytom. A"},{"key":"10.1016\/j.critrevonc.2025.104622_bib57","article-title":"Ex vivo expansion of circulating tumour cells (CTCs)","volume":"13","author":"Mohamed","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or Carboplatin\u2013Paclitaxel in Pulmonary Adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib59","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.21037\/tlcr-22-273","article-title":"Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients","volume":"11","author":"Mondelo-Mac\u00eda","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9010048","article-title":"Current status and future perspectives of liquid biopsy in small cell lung cancer","volume":"9","author":"Mondelo-Mac\u00eda","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2025.104622_bib61","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-16-2072","article-title":"Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers","volume":"77","author":"Murlidhar","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib62","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JTO.0b013e31823f125d","article-title":"Prognostic impact of circulating tumor cells in patients with small cell lung cancer","volume":"7","author":"Naito","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-010-0115-3","article-title":"Circulating tumor cells in colorectal cancer: past, present, and future challenges","volume":"11","author":"Negin","year":"2010","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib64","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.lungcan.2014.05.002","article-title":"Prognostic value of circulating tumor cells\u2019 reduction in patients with extensive small-cell lung cancer","volume":"85","author":"Normanno","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1515\/cclm-2022-0738","article-title":"Effect of short-term storage of blood samples on gene expression in lung cancer patients","volume":"61","author":"Obermayr","year":"2023","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2015.242537","article-title":"C.A.P. Res, Functional studies on viable circulating tumor Cells","volume":"62","author":"Pantel","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2025.104622_bib67","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","article-title":"Circulating Epithelial Cells in Patients with Benign Colon Diseases","volume":"58","author":"Pantel","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2025.104622_bib68","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/onc.2015.192","article-title":"The biology of circulating tumor cells","volume":"35","author":"Pantel","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104622_bib69","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jtho.2023.07.012","article-title":"Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry","volume":"18","author":"Pearsall","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib70","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2025.104622_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtho.2021.08.763","article-title":"Molecular subtypes of primary SCLC tumors and their associations with neuroendocrine and therapeutic markers","volume":"17","author":"Qu","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881989","article-title":"Organoids as a systems platform for SCLC brain metastasis","volume":"12","author":"Quaranta","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12935-019-0735-z","article-title":"Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo","volume":"19","author":"Que","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2025.104622_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040820","article-title":"Pathology and classification of SCLC","volume":"13","author":"Raso","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010114","article-title":"Expression of proteolytic enzymes by small cell lung cancer circulating tumor cell lines","volume":"11","author":"Rath","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib76","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtcvs.2015.09.126","article-title":"Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer","volume":"151","author":"Reddy","year":"2016","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"10.1016\/j.critrevonc.2025.104622_bib77","first-page":"245","article-title":"In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity","volume":"5","author":"de Renzi","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.critrevonc.2025.104622_bib78","first-page":"23","article-title":"Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation","volume":"63","author":"Resel Folkersma","year":"2010","journal-title":"Arch. Esp. Urol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib79","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1038\/s41598-023-30536-9","article-title":"Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer","volume":"13","author":"Ricordel","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib80","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/s41467-021-24164-y","article-title":"Notch signaling and efficacy of PD-1\/PD-L1 blockade in relapsed small cell lung cancer","volume":"12","author":"Roper","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104622_bib81","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2025.104622_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data HHS Public Access","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib83","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14737159.2020.1680287","article-title":"Liquid biopsy tracking of lung tumor evolutions over time","volume":"19","author":"Russo","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2025.104622_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10110949","article-title":"Integrated immunohistochemical study on small-cell carcinoma of the lung focusing on transcription and co-transcription factors","volume":"10","author":"Sato","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2025.104622_bib85","article-title":"Small cell lung cancer co-culture organoids provide insights into cancer cell survival after chemotherapy","author":"Sen","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.critrevonc.2025.104622_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050666","article-title":"Cell lines of circulating tumor cells: what is known and what needs to be resolved","volume":"12","author":"Shimada","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.critrevonc.2025.104622_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081983","article-title":"ALCAM: a novel surface marker on EpCAMlow circulating tumor cells","volume":"10","author":"Signorelli","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2025.104622_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108894","article-title":"Liquid biopsy in lung cancer: biomarkers for the management of recurrence and metastasis","volume":"24","author":"Souza","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104622_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.32604\/or.2022.027281","article-title":"Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells","volume":"31","author":"Stickler","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.critrevonc.2025.104622_bib90","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-021-00486-y","article-title":"Update 2021: Management of small cell lung cancer","volume":"199","author":"Tariq","year":"2021","journal-title":"Lung"},{"key":"10.1016\/j.critrevonc.2025.104622_bib91","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jtho.2019.04.026","article-title":"Durvalumab in combination with olaparib in patients with relapsed SCLC: results from a phase II study","volume":"14","author":"Thomas","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215719","article-title":"Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy","volume":"541","author":"Tian","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104622_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108296","article-title":"SCLC-cellminer: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures","volume":"33","author":"Tlemsani","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib94","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/clinchem\/hvac019","article-title":"Single-cell phenotypic and molecular characterization of circulating tumor cells isolated from cryopreserved peripheral blood mononuclear cells of patients with lung cancer and sarcoma","volume":"68","author":"Vismara","year":"2022","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2025.104622_bib95","article-title":"Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs)","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104622_bib96","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.7150\/jca.18032","article-title":"Systematic correlation analyses of circulating tumor cells with clinical variables and tumor markers in lung cancer patients","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104622_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115159","article-title":"A novel microfluidic system for enrichment of functional circulating tumor cells in cancer patient blood samples by combining cell size and invasiveness","volume":"227","author":"Wang","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.critrevonc.2025.104622_bib98","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1021\/acsami.5b12660","article-title":"Stimulation of early osteochondral differentiation of human mesenchymal stem cells using binary colloidal crystals (BCCs)","volume":"8","author":"Wang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2025.104622_bib99","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1039\/C5AN02554K","article-title":"Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation","volume":"141","author":"Wang","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.critrevonc.2025.104622_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216337","article-title":"Longitudinal detection of subcategorized CD44v6+\u2009CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: a prospective, multi-center study","volume":"571","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104622_bib101","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.mayocp.2019.01.034","article-title":"Current diagnosis and management of small-cell lung cancer","volume":"94","author":"Wang","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.critrevonc.2025.104622_bib102","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/cbin.11359","article-title":"New insights into small-cell lung cancer development and therapy","volume":"44","author":"Wang","year":"2020","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.critrevonc.2025.104622_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13030506","article-title":"Front line applications and future directions of immunotherapy in small-cell lung cancer","volume":"13","author":"Wong","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091111","article-title":"Circulating tumor cells: technologies and their clinical potential in cancer metastasis","volume":"9","author":"Xiao","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2025.104622_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061831","article-title":"Propagated circulating tumor cells uncover the potential role of NF\u03baB, EMT, and TGF\u03b2 signaling pathways and COP1 in metastasis","volume":"15","author":"Xiao","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104622_bib106","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/biot.201600084","article-title":"Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer","volume":"11","author":"Yamamoto","year":"2016","journal-title":"Biotechnol. J."},{"issue":"1979","key":"10.1016\/j.critrevonc.2025.104622_bib107","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.1253533","article-title":"Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility","volume":"345","author":"Yu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2025.104622_bib108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41392-023-01725-9","article-title":"New insights into the correlations between circulating tumor cells and target organ metastasis","volume":"8","author":"Zhan","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2025.104622_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215852","article-title":"PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy","volume":"545","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104622_bib110","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.18632\/oncotarget.2592","article-title":"Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104622_bib111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-023-01433-5","article-title":"The functional and clinical roles of liquid biopsy in patient-derived models","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104622_bib112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.20892\/j.issn.2095-3941.2018.0256","article-title":"Advances in isolation and detection of circulating tumor cells based on microfluidics","volume":"15","author":"Zou","year":"2018","journal-title":"Cancer Biol. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:23:03Z","timestamp":1778581383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":112,"alternative-id":["S1040842825000101"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104622","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small cell lung cancer unveiled: Exploring the untapped resource of circulating tumor cells-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104622"}}